
Orthofix International (OFIX) Stock Forecast & Price Target
Orthofix International (OFIX) Analyst Ratings
Bulls say
Orthofix Medical is well-positioned to experience continued growth due to its strong presence in the global spine market and its focus on providing innovative solutions for healthcare providers. With a diverse portfolio of products and services, the company is poised to benefit from the increasing demand for orthopedic and spine solutions. Furthermore, its solid financial performance, including a strong revenue and profit growth, exemplifies its ability to generate value for shareholders.
Bears say
Orthofix Medical is facing challenges with reimbursement for its bone growth stimulation products, leading to a downward adjustment in FY/26 guidance and the withdrawal of previous longer-term financial targets. While the company's Q1/26 revenue exceeded expectations, it did not provide further details on its performance and it is expected to be the low point for adjusted EBITDA and cash generation for the year. With the majority of its revenue coming from the global spine segment, these reimbursement challenges could significantly impact the company's financials and there are risks that the company may not meet revenue or earnings estimates to achieve its target price in the future.
This aggregate rating is based on analysts' research of Orthofix International and is not a guaranteed prediction by Public.com or investment advice.
Orthofix International (OFIX) Analyst Forecast & Price Prediction
Start investing in Orthofix International (OFIX)
Order type
Buy in
Order amount
Est. shares
0 shares